CHM chimeric therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-7

  1. 1,719 Posts.
    lightbulb Created with Sketch. 540
    2025!?

    You're very optimistic. I think we'll get topline results for the phase 1b end 2025.

    After that maybe a registrational phase 2? If we're lucky maybe FDA will allow additional enrollments to the phase 1b as the registrational phase 2 (not very familiar with how these breakthrough products progress through FDA hoops).

    I'm hoping 1101 will be FDA approved 2027-2028.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $8.137K 2.034M

Buyers (Bids)

No. Vol. Price($)
2 527743 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 15417457 24
View Market Depth
Last trade - 10.20am 23/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.